Wolverine Asset Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Wolverine Asset Management’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-254,194	Closed	-$4.57M	–	1967
2020 Q2	$4.57M	Buy	+254,194	New	+$3.54M	0.05%	231

Wolverine Asset Management's PTLA Position: Q3 2020 in Review

Wolverine Asset Management sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 254,194 shares — an estimated $4.57M sold.

Wolverine Asset Management first reported a position in PTLA in Q2 2020 and held it in 1 quarter. The position peaked at $4.57M in Q2 2020. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.

Wolverine Asset Management reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
Wolverine Asset Management sold 254,194 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $4.57M.
Wolverine Asset Management first reported a position in Portola Pharmaceuticals, Inc. in Q2 2020 and held it in 1 quarter.
Wolverine Asset Management's Portola Pharmaceuticals, Inc. position peaked at $4.57M in Q2 2020.
0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.

Based on Wolverine Asset Management's 13F filing for Q3 2020, filed 13 Nov 2020.